chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Minor sore arm day after vaccine. Sunday 10/24 Shortness breath was pretty bad. Chest was tight. Can breathe the whole way in, does not seem like anything was blocking, but the breathes did not feel like they were enough. Monday, it seemed like it subsided, every now and then it would come back for 2 weeks, I was concerned but it was not severe. Around the 5th, I had tightness of chest, and then that night I had a hard time falling asleep, then suddenly something strange happened in my sinus, and it felt weird then I got a severe migraine. The insomnia continued along with the headaches. The next day 8th I went to the Urgent Care, EKG-normal, x-ray-normal, Covid test- negative. I was frustrated because they couldn't tell me anything, and didn't really help, only that it could be anxiety. The next day I felt a little better then at night I had a headache again and couldn't slept. The following day I had a bad headache, so I went to another urgent care. At this UC they blood test-normal, tested thyroid- normal, they did notice my blood pressure was high 145/93 resting heart rate 88 BPM. They didn't give me any treatments, so looked it up myself and it said to keep sodium low and increase potassium so that's what I have been doing. I have just been monitoring it ad kept a journal of what was happening... This past weekend the symptoms came back and were pretty severe, Sunday, I started feeling week and nauseated. Monday had another headache and then began having a weird taste in my mouth, almost chemical like. Symptoms have continued. Difficulty breathing is the worse when I lay down. This weekend my hands would feel like their swollen and itchy. Burning sensation under my skin, noticed the most in my ears, arms and feet.
patient stated on Sunday on four separate occasions her left hand went flacid (i.e. she was unable to move it). She had gotten RSV and flu shot both in her left arm. RPh had recommended one in each are but pt said she has a lot of "hardware" in other arm so wanted both in left deltoid
First dose  1/18/2021 sore arm  4 days February 24, 2021 The second dose I was sick with chills, fever, headache, lethargic,  sore throat ,sore arm, fever 2 days  2 extra  days no fever but same other symptoms.  3/16/2021 had been fine up to this point  now  sore throat and headache have returned.
Patient developed immediate body aches following second dose, followed by headache, swelling and pain left side of face and ear. Diagnosed with bell's palsy, unresolved 10 days post vaccine.
Continued soreness in injection arm every day since first injection.  Near-continuous cognitive befuddlement / inability to think clearly - only have had this before with severe sinus infection / head cold (I'm a practicing degree'ed engineer - very scary to me).  Had a bout of "double vision" for approximately a minute - never had this before - another very scary thing.  Two days ago experienced "highway hypnosis" - zoned out while driving for 10 minutes - lost time event / can't remember driving the route I did - never had this before - another very scary thing.
This spontaneous report as received from a nurse practitioner refers to a patient of unknown age and gender. The patient's medical history, drug reactions or allergies and concomitant medications were not reported. On 13-JUL-2016, the patient was vaccinated orally with the first 2.0 ml dose of ROTATEQ (lot # L000433, expiry date 09-JUL-2016), which was expired. No adverse events were reported. Additional information has been requested.
dose 1 in October 2020/ dose#2 a month later/ did not get the third dose yet; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a 32-year-old female patient who received HBV (Engerix B adult) for prophylaxis.   Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis.   Previously administered products included Engerix B adult (received 1st dose in October 2020) and Engerix B adult (patient believes she received 2nd dose a month later in 2020).   On an unknown date, the patient received the 3rd dose of Engerix B adult and Engerix B Pre-Filled Syringe Device. On an unknown date, unknown after receiving Engerix B adult and Engerix B Pre-Filled Syringe Device, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The case was reported by the patient for herself. The age at vaccination was not applicable to this report. Till the time of reporting, the patient did not receive the 3rd dose of Engerix B adult, which led to incomplete course of vaccination. No further information was reported. The reporter did not consent to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021158159:possible same patient
Patient began to experience mild-to-moderate signs of allergic reaction about 10-15 seconds post-IM injection, including local swelling in deltoid region, redness, minor itching, and "tingling" that spread up and down (R) arm. Emergency squad transported patient to ER where she received BENADRYL 25 mg injection and was discharged in "stable" condition.
Expired vaccine used; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050E21A) for COVID-19 vaccination.     No Medical History information was reported.    In November 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In November 2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient received booster dose. No concomitant medications were reported. The vial was initially stored in the refrigerator on 04-Nov-2021. Dates of administration of vaccine Some were on 05-Nov-2021 and the other doses on 12-Nov-2021. The vial did not undergone any temperature excursions. HCP stated, no adverse event occurred as a result of this misadministration, patients were monitored. No treatment medications were reported.
I waited at the vaccine site for 15 min as instructed. Apx 5 min after leaving I began to feel lip tingling and light headed. I continued to drive home. Upon artiving at my home my symptoms worsened. Lightheaded, chest heaviness, violent tremor, mild headache began. I called y md and was instructed to call EMS & go to ER.. I was evaluated by EMS and told I was tachcardic and hypertensive. I was taken to ER. And arrived apx 2 hours after I had received vaccine . I was given IV steroids snd benedryl and valium for shaking.  I was tested for and ruled out for stroke, MI , pulmonary embolism.  I improved, but continued to have episodes of symptoms.  I was kept for 2 days of observation testing and treatment. I was discharged on medrol pack and xanax for shaking. I was instructed not to receive 2nd covid shot.  After discharge I experienced symptoms for over 3 months. I was seen by my md , cardiology, pulmonology and allergy after discharge . They all agreed that I should not take additional covid vaccines.
Watery diarrhea for 6 hrs, cramping abdominal pain for 12 hrs, frontal headache still present.
on 11/21/21 I had postnasal drip and a low cough.  On 11/23/21 I had night sweats and the two symptom's became more prevalent.  On 11/24//2021 I had a fever chills and tested positive for Covid-19.  I had an extremely high fever for three days, cough, congestion and I developed a rash on my back. Stop prompting the vaccine if it doesn't work.  I spent 10 days of my life isolated and sick due to an ineffective product.
Today I felt something in my mouth and it is on left side bottom of cheek.  A blood blister and my tongue has red bumps al over back of it.
All over body skin rash. Itching and discomfort  Measle like  Pityriasis rosea  Still having the rash today 4/28/2021 Nothing helps.
This spontaneous report was received from a physician refers to a couple of patients of unknown age and gender. On an unknown date, the patients were vaccinated with RECOMBIVAX HB (dose, route and lot # were not reported(). The patient's were non-responders to RECOMBIVAX HB. The outcome of were non-responders to RECOMBIVAX HB was unknown. Additional information has been requested.
she sad slight reaction-numbness in arm and slight chest pain, lasted the 10 minutes while she sat there and then it subsided.; she sad slight reaction-numbness in arm and slight chest pain, lasted the 10 minutes while she sat there and then it subsided.; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 56-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: unknown, Expiration date: unknown) via an unspecified route of administration, administered at an unspecified anatomical location on 02Jun2021 (age at vaccination was 56 years) as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 02Jun2021, immediately following the first vaccine, the patient experienced slight reaction-numbness in arm and slight chest pain, lasted for 10 minutes while she sat there and then it subsided. She received a response which stated that as noted in the fact sheet for recipients, you should not get the Pfizer-BioNTech COVID-19 Vaccine if you had a severe allergic reaction after a previous dose of the vaccine or if you had a severe allergic reaction to any ingredient of the vaccine. The decision to receive the second dose for any other reason cannot be made by Pfizer. They referred her to speak to her healthcare provider about the risks of the vaccine compared to the risks of potentially not being fully protected against COVID-19 infection. Her healthcare provider knows her health situation and had access to information that can better help inform this decision. The adverse event resulted in emergency room visit. She was scheduled for 2nd dose tomorrow. The outcome of event was resolved on 02Jun2021.  Information on the lot/batch number has been requested.
Son developed fever of 103 that was treated with Tylenol and ibuprofen. Fever lasted for 2 days. He also felt short of breath with general chest pain, especially when breathing deeper. This gradually subsided over 4-5 days. He had an increased heart rate over 100 at rest for about  2-3 days. Normal at rest heart rate in the 70s.
temperature reached to 32.2F for a total excursion time of 39 hours with no reported adverse event; patient was treated with MENQUADFI post-excursion with no reported adverse event; Initial information received on 23-Feb-2023 regarding an unsolicited valid non-serious case received from a consumer/non-healthcare professional.  This case is linked to cases 2023SA065072, 2023SA064856 and 2023SA064145.  This case involves a 11 years old male patient who experienced patient was treated with MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE [MENQUADFI] post-excursion with no reported adverse event and temperature reached to 32.2f for a total excursion time of 39 hours with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included HPV VACCINE VLP RL1 9V (YEAST) (GARDASIL 9) and DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR 3-COMPONENT, TETANUS VACCINE TOXOID (BOOSTRIX) for Immunisation.  On 14-Feb-2023, the patient received 0.5 ml dose of suspect meningococcal A-C-Y-W135 (T CONJ) vaccine, Solution for injection (frequency, once (1x), strength - standard, expiry date- 28-Feb-2025,  lot U7576AB) via intramuscular route in right deltoid for prophylactic vaccination.  On 14-FEB-2023 the patient developed a non-serious patient was treated with menquadfi post-excursion with no reported adverse event (poor quality product administered) (latency same day) following the administration of MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE.  It was reported that temperature reached to 32.2f for a total excursion time of 39 hours with no reported adverse event (product storage error).  Action taken with MENINGOCOCCAL VACCINE (MENQUADFI) was not applicable.  At time of reporting, the outcome was Unknown for both events    This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments:  US-SA-2023SA064856:
very faint pink rash shaped as a band that was 2 inches wide and about 1 inch below the injection site; just a little itchy; This spontaneous case was reported by a consumer and describes the occurrence of RASH (very faint pink rash shaped as a band that was 2 inches wide and about 1 inch below the injection site) and PRURITUS (just a little itchy) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure, Cholesterol, Hypothyroidism, GERD, Anxiety and Sleep disorder NOS. Concomitant products included ALPRAZOLAM for Anxiety, QUETIAPINE FUMARATE (SEROQUEL) for Sleep disorder NOS.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Dec-2020, the patient experienced RASH (very faint pink rash shaped as a band that was 2 inches wide and about 1 inch below the injection site) and PRURITUS (just a little itchy). At the time of the report, RASH (very faint pink rash shaped as a band that was 2 inches wide and about 1 inch below the injection site) and PRURITUS (just a little itchy) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Current condition includes blood pressure, cholesterol, hypothyroidism and Gastroesophageal reflux disease, anxiety, sleep. Concomitant medications were medicine for her blood pressure, cholesterol, hypothyroidism and Gastroesophageal reflux disease,  Alprazolam for her anxiety and Seroquel for sleep. Treatment details included For the symptoms: Kenalog cream.,
This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 71-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 10Feb2021 as dose 1, single (Lot number: EL 8982), on 10Mar2021 as dose 2, single (Lot number: EN 6208) and on 29Sep2021 as dose 3 (booster), single (Lot number: 30125BA) at the age of 70 years for Covid-19 immunisation. The patient's relevant medical history included: "known allergies: Penicillin" (unspecified if ongoing), notes: known allergies: Penicillin; "Sarcoidosis of the lung and heart" (unspecified if ongoing), notes: other medical history: Sarcoidosis of the lung and heart; "Sarcoidosis of the lung and heart" (unspecified if ongoing), notes: other medical history: Sarcoidosis of the lung and heart; "high blood pressure" (unspecified if ongoing); "high cholesterol" (unspecified if ongoing); "osteoarthritis" (unspecified if ongoing). Concomitant medication(s) included: AMLODIPINE; METOPROLOL SUCCINATE; OMEPRAZOLE; FOLIC ACID; PREDNISONE; METHOTREXATE; PREMARIN; RESTASIS; ASPIRIN 81; VITAMIN D3; FISH OIL; PROBIOTIC [BIFIDOBACTERIUM LACTIS]; BIOTIN, CITRICAL SLOW RELEASE CALCIUM and MULTIVITAMIN. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset May2022, outcome "unknown" and all described as "Tested positive for Covid using home test kit on 12May2022". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (12May2022) Positive; (19May2022) Negative; (21May2022) Positive. Therapeutic measures were taken as a result of vaccination failure, Covid-19. Clinical information: It was reported that the patient took other medications in 2 weeks.
Site: Bruising at Injection Site-Mild, Site: Itching at Injection Site-Mild, Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Systemic: Fainting / Unresponsive-Mild, Additional Details: After administration of Jansen vaccine in less than one minute, patiet had a syncopal episode. He recovered within few minutes. Vital sigs within normal range. He stated he had not eaten or drink anything since night before. 911 was called.
Information has been received from a physician concerning a 15 year old male patient who on 07-AUG-1996 and 01-NOV-1998, was vaccinated with the first and second doses of MMR II, respectively. On 10-NOV-2009 the patient experienced mumps. On 29-NOV-2009, the patient was diagnosed. The patient was afebrile and had left parotitis. The parotitis count was 64. At the time of the report, the outcome was unknown. Follow up information was received which reported that on 29-DEC-2009 the patient experienced mumps again. On 31-DEC-2009, the patient was diagnosed. The patient was afebrile and had right parotitis. On 31-DEC-2009, the first blood work was performed (no result provided). At the time to the report, the outcome was unknown. No further information is available.
Headache, Sedation, Myalgia, Arthralgia, Fever, INSOMNIA, SORE THROAT, CHILLS, RESTLESS ARMS AND LEGS Narrative:
Unable to move arm Body aches Pain at injection site Muscle ache (From neck to right arm, back pain, chest pain)
patient received dose from vials beyond 30-day use by date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient received dose from vials beyond 30-day use by date) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient received dose from vials beyond 30-day use by date). On 16-Jun-2021, EXPIRED PRODUCT ADMINISTERED (patient received dose from vials beyond 30-day use by date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment information was provided. It was reported that Date of refrigeration of vaccine was 05/07/21   This case was linked to MOD-2021-363032 (Patient Link).
2 days after receiving 2nd COVID 19 vaccination, woke up with  pain, tenderness, and swollen left armpit. Received vaccination on left arm
- body aches - chills - fever (99.6 deg at 10:00 am, 07/26/2019) - fever (100.9 deg at 4:00 PM, 07/26/2019)
Lymph node in her clavicle area that is swollen and tender to touch; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Lymph node in her clavicle area that is swollen and tender to touch) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN 81) for an unknown indication.    On 09-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced LYMPHADENOPATHY (Lymph node in her clavicle area that is swollen and tender to touch). The patient was treated with IBUPROFEN for Swelling, at a dose of 1 UNK. At the time of the report, LYMPHADENOPATHY (Lymph node in her clavicle area that is swollen and tender to touch) outcome was unknown.
VACCINE ADMINISTERED AFTER BUD OF 6/22/22 WITHOUT REPORT OF ADVERSE EFFECT.
Onset 3/28/03 HA, backache, muscle aches, joint pain, dizziness, itching, indigestion for 2 days.
Do you expect the Moderna booster to have side effects similar to the second dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Do you expect the Moderna booster to have side effects similar to the second dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Do you expect the Moderna booster to have side effects similar to the second dose). At the time of the report, VACCINATION COMPLICATION (Do you expect the Moderna booster to have side effects similar to the second dose) outcome was unknown.            the treatment history was not reported.  The concomitant medication was not reported.   Reporter did not allow further contact
NAUSEA; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included penicillin allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, and batch number: 1805018 expiry: UNKNOWN) dose was not reported, administered on 12-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 12-MAR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from nausea. This report was non-serious.
Within 12 hours of the injection I became achy, had pain in left upper arm and had insomnia. As the next 12 hours progressed, I developed worsening chills, body aches, dizziness, nausea, severe headache and fever of at least 103.5. There was a point when I wanted to take my temperature but I was literally too ill to get out of the bed to get the thermometer. MOTRIN only reduced fever to 101.3. Within 72 hours, the symptoms gradually subsided with just a little bit of dizziness and headache persisting. There was never any redness or swelling at the injection site, just pain all the way to the elbow.
Got Pneumovax 23 injection. 10 hours later experienced swelling and pain in my arm; nausea; fainting; and my lungs filled with fluid. Took Benadryl. Symptoms subsided over the next 2-4 hours except for the arm pain and swelling.
Pt received a tetanus toxoid 28 years ago at age 7 and subsequently develop a nodule at the injection site which was resolved within several days.